NEWS & EVENTS
Biomedica Participates in the "AI with Purpose Global Summit": Advancing Responsible and Sustainable AI in Healthcare
June 18,2025
.jpeg)
Our Chief Strategy Officer, Dr. Chris Kuo, joined expert panelists to discuss how AI technologies can enhance diagnostic accuracy, optimize healthcare operations, and create measurable economic and clinical value, particularly in under-resourced and aging populations.
This international summit focused on how AI technologies are becoming a driving force for sustainable development, social inclusion, and economic prosperity. As a leader in smart healthcare, Biomedica was invited to the summit to share our innovative AI medical applications and global accomplishments.
AI-Powered Healthcare: Enhancing Efficiency and Revenue
At the summit, Biomedica showcased how our AI solutions are addressing the limitations of traditional bone density (DXA) diagnostics, which are costly and not widely accessible. Our AI-powered osteoporosis screening system integrates with existing X-ray equipment to analyze images and generate reports within just six seconds. This significantly improves diagnostic efficiency, helps hospitals save millions in treatment costs, and creates new revenue streams of up to NT$90 million annually.
Hospitals can quickly adopt this solution with zero upfront investment, enabling smarter diagnostics that benefit both operations and patient outcomes.
Empowering Collaborative Care: Creating New Value Together
We also explored how AI is reshaping the roles of patients, clinicians, and caregivers:
-
Patients can better understand their health data and actively participate in care decisions.
-
Physicians gain real-time, accurate diagnostic support from AI tools that interpret images, predict disease risks, and suggest personalized treatment options.
-
Caregivers can access real-time health updates via smart monitoring systems and use AI-powered communication tools to provide better support.
AI enhances collaboration across the care continuum, making healthcare more efficient, precise, and patient-centric.
Looking Ahead: Breakthroughs in Generative AI and Precision Medicine
Biomedica is also leading in the development of next-generation AI solutions. Our latest AI diagnostic models can help detect early signs of endometrial cancer via ultrasound—an area traditionally difficult to diagnose in its early stages. This enables timely follow-ups or biopsies during the critical early stages (Stage 1 or 2), avoiding missed treatment windows.
We are also advancing AI-powered analysis of RNA-related gene defects. By analyzing large-scale genomic data, AI can identify pathological changes at the RNA level, predict drug responses, and match patients with optimal personalized therapies—improving treatment outcomes while creating new revenue models for medical institutions.
Global Collaboration for a Responsible AI Future
Biomedica believes that AI must be both effective and responsible. We are honored to join organizations such as TEEMA, GeSI, and Taiwan Mobile in setting a global benchmark for the ethical application of AI.
Moving forward, we will continue developing AI solutions that are practical, sustainable, and scalable—ensuring that smart healthcare becomes not just an innovation, but a standard accessible to all.
.jpeg)